Neurocrine Bioscience buy JPMorgan Chase & Co.
Start price
13.09.23
/
50%
€107.25
Target price
13.09.24
€124.83
Performance (%)
3.78%
Price
28.08.24
€111.30
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 3.78%. This prediction currently runs until 13.09.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | -17.708% | -17.708% |
iShares Core DAX® | 1.743% | 1.903% |
iShares Nasdaq 100 | -2.088% | -0.640% |
iShares Nikkei 225® | 1.306% | 4.161% |
iShares S&P 500 | -0.093% | 0.169% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at JPMorgan Chase & Co. from $133.00 to $134.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€132.10
07.08.24
07.08.24
€165.67
07.08.25
07.08.25
-15.75%
28.08.24
28.08.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.00
10.07.24
10.07.24
€159.75
10.07.25
10.07.25
-17.56%
28.08.24
28.08.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€128.85
20.03.24
20.03.24
€145.64
20.03.25
20.03.25
-13.62%
28.08.24
28.08.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.00
23.02.24
23.02.24
€136.69
23.02.25
23.02.25
-10.24%
28.08.24
28.08.24